Drug recall · July 8, 2015
CONTRAVE recall
Why: Failed Tablet/Capsule Specifications: Potential tablet defect of broken tablets and/or equatorial splitting of the bilayer tablets into the two drug components.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
CONTRAVE (naltrexone HCl and bupropion HCl )extended-release tablets, 8 mg/ 90 mg, 120-count bottle, Rx only, Manufactured for Orexigen Therapeutics, Inc., La Jolia, CA 92037, Distributed by Takeda Pharmaceuticals America, Inc., Deerfield, IL 60015, NDC 64764-890-99.
- Lots / codes
Lot # B21642; Exp. 03/17
- Quantity
- 3,619 bottles
- Company
- Takeda Pharmaceuticals North America, Inc., Deerfield, IL
- Distribution
- Nationwide
- Initiated
- May 21, 2015 · Voluntary: Firm initiated
- Classified
- July 2, 2015
- Reported
- July 8, 2015
- Ended
- February 20, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bupropion
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.